The biomarkers of HCC cell surface such as epithelial cell adhesion molecule (EpCAM) [48] and Glypican-3 (GPC3) [49] are amenable for the development of photodynamic immunotherapy based on antibody-photosensitizer conjugate (APC) strategy. Here, GPC3 is linked to hepatocellular carcinoma.